Detrimental effects of N-acetylcysteine plus desferoxamine combination in an experimental nephrotic syndrome model

被引:6
作者
Bulucu, F. [1 ]
Oktenli, C. [2 ]
Kenar, L. [3 ]
Koc, B. [1 ]
Ocal, R. [1 ]
Karadurmus, N. [1 ]
Inal, V. [1 ]
Yamanel, L. [1 ]
Sanisoglu, Y. S. [4 ]
Aydin, A. [5 ]
机构
[1] Gulhane Mil Med Acad, Dept Internal Med, TR-06018 Ankara, Turkey
[2] GATA Haydarpasa Training Hosp, Div Internal Med, Istanbul, Turkey
[3] Gulhane Mil Med Acad, Dept Biochem, Ankara, Turkey
[4] Turkish Mil Hlth, Dept Monitoring & Evalulat, Ankara, Turkey
[5] Gulhane Mil Med Acad, Dept Pharmaceut Sci, Ankara, Turkey
关键词
desferoxamine; doxorubicin; N-acetylcysteine; nephrotic syndrome;
D O I
10.1080/10915810701707403
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The aim of this study was to evaluate the effects of N-acetylcysteine (NAC) and desferoxamine (DFO) administered alone or in combination together in rats with doxorubicin(DOX)-induced nephrotic syndrome, by monitoring oxidative stress parameters and trace elements in renal tissue and erythrocytes. Fifty-four male Sprague-Dawley rats were included the study. Equal volume of isotonic saline was injected to control rats. After DOX administration, the animals were divided into four experimental groups: ( a) rats given only DOX; (b) rats treated with NAC; (c) rats treated with DFO; (d) rats treated with NAC plus DFO. The combination of N-acetylcysteine and DFO has no beneficial effect on reducing proteinuria in experimentally nephrotic rats, although both of these agents ameliorate the condition when administered separately. It seems likely that detrimental effects of NAC plus DFO could be secondary to its effects on erythrocyte selenium levels demonstrated here. Consequently, the results may propose caution to the use of antioxidant therapeutic strategies such as NAC plus DFO against nephropathy.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 40 条
[1]
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[2]
THE ANTIOXIDANT ACTION OF N-ACETYLCYSTEINE - ITS REACTION WITH HYDROGEN-PEROXIDE, HYDROXYL RADICAL, SUPEROXIDE, AND HYPOCHLOROUS ACID [J].
ARUOMA, OI ;
HALLIWELL, B ;
HOEY, BM ;
BUTLER, J .
FREE RADICAL BIOLOGY AND MEDICINE, 1989, 6 (06) :593-597
[3]
Oxidative stress and nitric oxide related parameters in type II diabetes mellitus:: effects of glycemic control [J].
Aydin, A ;
Orhan, H ;
Sayal, A ;
Özata, M ;
Sahin, G ;
Isimer, A .
CLINICAL BIOCHEMISTRY, 2001, 34 (01) :65-70
[4]
EFFECT OF N-ACETYLCYSTEINE ON THE PULMONARY RESPONSE TO ENDOTOXIN IN THE AWAKE SHEEP AND UPON INVITRO GRANULOCYTE FUNCTION [J].
BERNARD, GR ;
LUCHT, WD ;
NIEDERMEYER, ME ;
SNAPPER, JR ;
OGLETREE, ML ;
BRIGHAM, KL .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (06) :1772-1784
[5]
BERTANI T, 1982, LAB INVEST, V46, P16
[6]
BERTOLATUS JA, 1991, J LAB CLIN MED, V118, P435
[7]
BORG D C, 1986, Journal of Free Radicals in Biology and Medicine, V2, P237, DOI 10.1016/S0748-5514(86)80004-6
[8]
Bulucu F, 2000, CLIN NEPHROL, V53, P169
[9]
Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity - Role of reactive oxygen species and ferritin [J].
Corna, G ;
Santambrogio, P ;
Minotti, G ;
Cairo, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (14) :13738-13745
[10]
Desferoxamine (DFO) - mediated iron chelation: rationale for a novel approach to therapy for brain cancer [J].
Dayani, PN ;
Bishop, MC ;
Black, K ;
Zeltzer, PM .
JOURNAL OF NEURO-ONCOLOGY, 2004, 67 (03) :367-377